Related Experiment Videos
[Histoplasmosis: not only a tropical disease]
E R Bregani1, T Van Tien, T Ceraldi
1Divisione di Medicina d'Urgenza, Ospedale Maggiore, IRCCS, Policlinico, Milano. rino_bregani@yahoo.it
Abstract:
Histoplasmosis is a fungal infection resulting from inhalation of spores from the fungus Histoplasma capsulatum; it is known to be endemic in various parts of the world, especially in North and Latin America, and can produce a spectrum of illness, from subclinical infection to progressive disseminated disease. The majority of infected persons have an asymptomatic, self-limiting illness. Clinical pneumonia occurs in those with exposure to a large number of infecting spores. Disseminated histoplasmosis usually occurs in immunosuppressed patients or in patients with chronic illness. Diagnosis is best made by visualization of yeast in tissue or by culture. In most cases, amphotericin B is the initial drug of choice, followed by one of the azoles for lifelong maintenance therapy. Itraconazole is the drug of choice for treatment of disseminated histoplasmosis in less severe cases, while fluconazole therapy for histoplasmosis is only moderately effective.
Insights
Histoplasmosis, a fungal infection from Histoplasma capsulatum spores, typically causes mild illness but can lead to severe disease in immunocompromised individuals. Diagnosis involves yeast visualization or culture, with amphotericin B and azoles as primary treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Histoplasmosis is a globally endemic fungal infection caused by Histoplasma capsulatum spores.
- It presents a spectrum of illness, from asymptomatic infections to severe disseminated disease.
- Risk factors for severe disseminated histoplasmosis include immunosuppression and chronic illnesses.
Purpose of the Study:
- To summarize the epidemiology, clinical presentation, diagnosis, and treatment of histoplasmosis.
- To highlight diagnostic methods and therapeutic strategies for Histoplasma capsulatum infections.
Main Methods:
- Review of literature on Histoplasma capsulatum infections.
- Analysis of diagnostic techniques, including microscopy and culture.
- Evaluation of treatment guidelines for histoplasmosis.
Main Results:
- Most Histoplasma capsulatum infections are asymptomatic and self-limiting.
- Pneumonia can occur with high spore exposure; disseminated disease is common in immunocompromised patients.
- Amphotericin B is the initial treatment, followed by azoles for maintenance; itraconazole is preferred for less severe disseminated cases.
Conclusions:
- Early diagnosis and appropriate treatment are crucial for managing histoplasmosis.
- Treatment strategies vary based on disease severity and patient immune status.
- Fluconazole shows only moderate efficacy in treating histoplasmosis.